From its initial use in the treatment of type 2 diabetes to its expansion to 12 indications such as obesity, cardiovascular disease, chronic kidney disease, and metabolic dysfunction related fatty liver disease (MASLD), the annual sales of GLP-1 drugs exceeded 100 billion dollars, and its research and development funding reached a historical peak of 21.72 million dollars in 2025
Weight fluctuations can profoundly affect reproductive hormones
How should elevated B12 be interpreted in chronic kidney disease or chronic liver disease
While youre taking GLP-1 medications, opt for smaller, more frequent meals to keep nausea at bay
Inflammation drives a lot of knee pain, and recovery from knee surgery can feel slow
He outlined their potential mechanisms, reviewed emerging evidence supporting their benefits, and summarized known side effects and contraindications